New radiofrequency wire aims to make heart procedures safer

NCT ID NCT07361445

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a new device that uses a special wire with radiofrequency energy to safely cross the wall between the heart's upper chambers. This step is needed for procedures that treat heart rhythm problems or close the left atrial appendage. The study will enroll 60 adults and follow them only until they leave the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Agilis RF Transseptal System (radiofrequency wire device)
What this could lead to
If successful, this device could make heart procedures safer and more reliable by improving how doctors access the left side of the heart.
What could go wrong
This is a very early, first-in-human study with only 60 people and no long-term follow-up. The device may not work as expected or could cause complications like heart injury or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arrhythmia Research Group (St. Bernards)

    RECRUITING

    Jonesboro, Arkansas, 72401, United States

  • California Pacific Medical Center -Van Ness Campus

    RECRUITING

    San Francisco, California, 94109, United States

  • Research Medical Center

    RECRUITING

    Kansas City, Missouri, 64132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.